CSIMarket Company Name, Ticker, Suppliers, else..


Marker Therapeutics inc   (NASDAQ: MRKR)
Other Ticker:  
 

Marker Therapeutics inc

MRKR's Fundamental analysis



Marker Therapeutics Inc 's sales fell by -26.35 % in the second quarter of 2025 from the same quarter a year ago. Ranking at No. 20

Major Pharmaceutical Preparations industry recorded growth of revenues by 8.14 %

Marker Therapeutics Inc net loss increased from $-2 millions, to $-4 millions in second quarter of 2025,

• More on MRKR's Growth


Marker Therapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 3.34 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.49.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.86.


• More on MRKR's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 81,637
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.75

Marker Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 3.34 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.49.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.86.

Marker Therapeutics Inc Price to Book Ratio is at 1.28 lower than Industry Avg. of 105.04. and higher than S&P 500 Avg. of 0.02

• More on MRKR's Valuation

•  Market Capitalization (Millions $) 13
•  Shares Outstanding (Millions) 14
•  Employees 66
•  Revenues (TTM) (Millions $) 5
•  Net Income (TTM) (Millions $) -15
•  Cash Flow (TTM) (Millions $) 4
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 81,637
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 0.75

•  Market Capitalization (Millions $) 13
•  Shares Outstanding (Millions) 14
•  Employees 66
•  Revenues (TTM) (Millions $) 5
•  Net Income (TTM) (Millions $) -15
•  Cash Flow (TTM) (Millions $) 4
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 3.45
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.41
•  Asset Turnover Ratio (TTM) 0.33
•  Inventory Turnover Ratio (TTM) -





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.